Squamous cell carcinoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
The c-MYC expression is associated with histological grade (<i>P</i>=0.0205) of patients with oral squamous cell carcinoma.
|
31239771 |
2019 |
Squamous cell carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Notch and MYC-driven murine lung tumours recapitulated the SCC-distinguishing metabolic reprogramming.
|
31114017 |
2019 |
Squamous cell carcinoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Overexpression of the c-MYC was detected in 61.05% (58/95) esophageal squamous cell carcinomas, which was significantly correlated with the degree of differentiation (p = 0.004).
|
28671049 |
2017 |
Squamous cell carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Immunohistochemistry was used to identify c-MYC in a group of 104 tongue squamous cell carcinomas with an antibody directed against the N-terminal part of the protein.
|
28393404 |
2017 |
Squamous cell carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
The lung cancer subtypes share some genetic variations such as the dysfunction of tumor suppressor gene TP53, and also harbor specific variations of their own such as MET in ADC, FGFR1 and FGFR3 in SCC and MYC in SCLC.
|
27845189 |
2017 |
Squamous cell carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Transcription factor enrichment analysis identified c-MYC as a hub of miR-203-induced transcriptomic changes in squamous cell carcinoma.
|
27452220 |
2016 |
Squamous cell carcinoma
|
0.400 |
Biomarker
|
disease |
CTD_human |
PIAS3, SHP2 and SOCS3 Expression patterns in Cervical Cancers: Relevance with activation and resveratrol-caused inactivation of STAT3 signaling.
|
26432044 |
2015 |
Squamous cell carcinoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
These results demonstrate that RSK activation of eIF4B is causally linked to elevated Lamγ2 and MYC protein levels during neoplastic progression to invasive SCC.
|
24205356 |
2013 |
Squamous cell carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Evaluation of MYC status in oral lichen planus in patients with progression to oral squamous cell carcinoma.
|
23461699 |
2013 |
Squamous cell carcinoma
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
EGFR and MYC gene copy number aberrations are more common in squamous cell carcinoma than keratoacanthoma: a FISH study.
|
23521519 |
2013 |
Squamous cell carcinoma
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
MYC gains were identified in 4 of 11 in situ carcinomas (36%) and 50 of 68 invasive penile squamous cell carcinomas (73%).
|
22999547 |
2012 |
Squamous cell carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
MYC numerical aberrations were more frequent in moderately to poorly differentiated SCCs (77%) when compared with well-differentiated SCCs (25%; P = 0.027).
|
19673870 |
2009 |
Squamous cell carcinoma
|
0.400 |
Biomarker
|
disease |
LHGDN |
Induction of c-Myc-dependent cell proliferation through toll-like receptor 3 in head and neck cancer.
|
18204787 |
2008 |
Squamous cell carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
C-myc gene amplification was present in 8 out of 77 surgically treated SCC (10.4%) and in 13 out of 43 multimodally treated SCC (30.2%).
|
12820414 |
2003 |
Squamous cell carcinoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Here, expression of p53 and c-myc protein was studied in oral SCCs from this etiologically distinct population by immunohistochemistry.
|
9786319 |
1998 |
Squamous cell carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
We conclude that TGF-beta 1 activates multiple cell cycle inhibitory pathways dependent upon p21waf1 induction and c-MYC degradation and that it does not function as a tumor suppressor in the majority of SCCs.
|
8891333 |
1996 |
Squamous cell carcinoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
We have examined the c-myc gene expression and the gene organization in resected human esophageal squamous cell carcinomas, and in the adjacent normal esophageal mucosa from 20 patients undergoing radical surgery.
|
1444241 |
1992 |
Squamous cell carcinoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Fifteen primary non-small-cell lung carcinomas (8 adenocarcinomas and 7 squamous-cell carcinomas) were analyzed by multiparameter flow cytometry for their expression of p53 and c-myc proteins.
|
1334053 |
1992 |